This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
79
370 megabecquerel (MBq) IV single-dose
positron emission tomography (PET) scan
Banner Alzheimer's Institute
Phoenix, Arizona, United States
Change in Tau Deposition Over Time by Diagnostic Group and Amyloid Status
Change in flortaucipir standardized uptake value ratio (SUVr) over 18 months. For SUVr, a value of 1 signifies no flortaucipir activity above background, values greater than 1 signify increasing flortaucipir activity in the brain. A positive change in SUVr represents an increase in tau deposition in the brain. Change = 18 month SUVr - baseline SUVr obtained in Study A05.
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Imaging Endpoints
Scottsdale, Arizona, United States
Mayo Clinic Arizona
Scottsdale, Arizona, United States
Banner Sun Health Research Institute
Sun City, Arizona, United States
Institute for Brain Aging and Dementia, UC Irvine
Irvine, California, United States
21st Century Oncology
Newport Beach, California, United States
Alzheimer's Disease Center, UC Davis
Sacramento, California, United States
California Medical Clinic for Headache
Santa Monica, California, United States
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida, United States
Compass Research, LLC
Orlando, Florida, United States
...and 12 more locations